Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,730
-220 (-1.58%)
Apr 2, 2026, 3:30 PM KST

KRX:271980 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
48,87453,47632,99131,44625,963
Short-Term Investments
4,2693,9802,667142.462,040
Trading Asset Securities
5,689----
Cash & Short-Term Investments
58,83257,45535,65831,58928,003
Cash Growth
2.40%61.13%12.88%12.80%325.06%
Accounts Receivable
136,848160,467150,955137,807129,424
Other Receivables
4,13613,44015,17115,45415,265
Receivables
140,984173,908166,126153,262146,689
Inventory
104,475104,427109,76899,151102,458
Prepaid Expenses
515.62214.62327.84291.88186.71
Other Current Assets
6,8167,0315,1677,3487,336
Total Current Assets
311,621343,036317,046291,641284,672
Property, Plant & Equipment
147,726146,166137,041138,402125,710
Long-Term Investments
25,0168,3427,3436,7985,032
Other Intangible Assets
8,8544,9944,3203,8883,762
Long-Term Accounts Receivable
-00-000
Long-Term Deferred Tax Assets
9,2597,4285,359172.391,452
Long-Term Deferred Charges
6,5838,3788,5615,494-
Other Long-Term Assets
1,5157,3567,65610,4965,858
Total Assets
510,575525,700487,326456,892426,486
Accounts Payable
89,019134,562144,338151,641153,084
Accrued Expenses
170.84178.21160.7499.9129.33
Short-Term Debt
90,48771,00064,77240,57624,166
Current Portion of Long-Term Debt
---2,5006,125
Current Portion of Leases
1,8451,9711,9461,8321,915
Current Income Taxes Payable
1,7943,588448.241,049114.57
Other Current Liabilities
59,13780,39192,71062,66736,509
Total Current Liabilities
242,454291,690304,375260,366221,943
Long-Term Debt
---3,9998,977
Long-Term Leases
1,0842,7254,4525,4436,617
Pension & Post-Retirement Benefits
15,91811,7716,73325.041,262
Other Long-Term Liabilities
94.11197.01938.5223,17020,339
Total Liabilities
259,549306,383316,499293,003259,139
Common Stock
7,3527,3527,3527,3527,352
Additional Paid-In Capital
206,399206,223155,296155,296155,296
Retained Earnings
-29,336-52,296-19,660-20,321-10,414
Treasury Stock
-4,829-4,829-4,829-4,829-4,432
Comprehensive Income & Other
31,48431,69920,41020,41020,410
Total Common Equity
211,071188,150158,570157,909168,213
Minority Interest
39,95431,167-1,538-2,312-866.16
Shareholders' Equity
251,025219,317170,828163,889167,347
Total Liabilities & Equity
510,575525,700487,326456,892426,486
Total Debt
93,41675,69571,17054,35047,800
Net Cash (Debt)
-34,585-18,240-35,513-22,761-19,797
Net Cash Per Share
-2373.77-1252.00-2437.13-1561.68-1355.11
Filing Date Shares Outstanding
14.5614.5714.5714.5714.58
Total Common Shares Outstanding
14.5614.5714.5714.5714.58
Working Capital
69,16851,34512,67131,27562,729
Book Value Per Share
14493.4112912.1610882.2010836.8311533.52
Tangible Book Value
202,217183,156154,250154,021164,451
Tangible Book Value Per Share
13885.4412569.4410585.7110570.0211275.56
Land
54,46153,69840,61340,58630,106
Buildings
107,964105,484103,864103,864102,213
Machinery
93,16488,78788,62282,31576,560
Construction In Progress
6,0824,7243,0703,7172,390
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.